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Abstract
Objective: To determine the association between excess body fat, assessed by
skinfold thickness, and the incidence of type 2 diabetes mellitus (T2DM) and
hypertension (HT).
Design:Data from the ongoing PERUMIGRANT Study were analysed. The outcomes
were T2DM and HT, and the exposure was skinfold thickness measured in bicipital,
tricipital, subscapular and suprailiac areas. The Durnin–Womersley formula and SIRI
equation were used for body fat percentage estimation. Risk ratios and population
attributable fractions (PAF) were calculated using Poisson regression.
Setting: Rural (Ayacucho) and urban shantytown district (San Juan de Miraflores,
Lima) in Peru.
Participants: Adults (n 988) aged ≥30 years (rural, rural-to-urban migrants, urban)
completed the baseline study. A total of 785 and 690 were included in T2DM and
HT incidence analysis, respectively.
Results: At baseline, age mean was 48·0 (SD 12·0) years and 47% were males. For
T2DM, in 7·6 (SD 1·3) years, sixty-one new cases were identified, overall incidence
of 1·0 (95%CI 0·8, 1·3) per 100 person-years. Bicipital and subscapular skinfoldswere
associated with 2·8-fold and 6·4-fold risk of developing T2DM. On the other hand, in
6·5 (SD 2·5) years, overall incidence of HT was 2·6 (95% CI 2·2, 3·1) per 100
person-years. Subscapular and overall fat obesity were associated with 2·4- and
2·9-fold risk for developing HT. The PAF for subscapular skinfold was 73·6 and
39·2 % for T2DM and HT, respectively.
Conclusions:We found a strong association between subscapular skinfold thickness
and developing T2DM and HT. Skinfold assessment can be a laboratory-free strategy
to identify high-risk HT and T2DM cases.
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In 2016, nearly 18 million deaths were caused by CVD,
accounting for one-third of the global deaths. In the last
decade, the impact of the increasing prevalence of non-
communicable diseases has been observed in low- and
middle-income countries, where approximately 75% of the
global deaths related to CVD occurred(1,2). Hypertension
(HT) and type 2 diabetes mellitus (T2DM) are the strongest
modifiable risk factors for CVD and the subsequent mortal-
ity(3). HT is the main risk factor for CVD(4), which accounts
for more than two-thirds of the total deaths associated
with non-communicable diseases. On the other hand,
$US 827 billion are expended annually in patients with
T2DM worldwide(5).
A common major risk factor for CVD is obesity, with a
global prevalence among adults of 13 % in 2016(6). The
WHO defines obesity as an excess of body fat and recom-
mends using BMI to assess it, as BMI is a simple tool to use
in routine clinical examinations(7). However, BMI does not
differentiate fat percentage from lean mass. Therefore, the
obesity diagnosis obtained by it is not necessarily corre-
lated with body fat percentage (BF%), which is associated
with CVD or metabolic disturbances(8,9). Waist circumfer-
ence (WC) is another anthropometric marker with a dem-
onstrated association with T2DM and HT and represents
the abdominal fat and android distribution of fat(10). The
gold standards to quantify BF% as well as describe its
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distribution are dual-energy X-ray absorptiometry and
skinfold thickness assessment(11). Skinfold thickness, being
one of the recommended standards for excess of BF %,
remains understudied in its relationship with major cardio-
metabolic risk factors such as T2DM and HT. In terms of
longitudinal evaluations, only two studies from developing
countries have explored the association between skinfold
thickness results and developing T2DM, and only one of
these considered HT as an additional outcome(12,13).
Accordingly, we aimed to determine the association
between excess of body fat, estimated by skinfold thick-
ness using four different regions (i.e. bicipital, tricipital,
subscapular, suprailiac), and the risk of developing
T2DM and HT using information of the PERU MIGRANT
Cohort Study.We hypothesized that excess of BF % accord-
ing to skinfold thickness would demonstrate a greater
association with T2DM and HT than that observed with tra-
ditional anthropometric markers.
Methods
Study design
Weanalyseddata from thePERUMIGRANTStudy, a prospec-
tive ongoing cohort for which baseline assessment was con-
ducted in 2007–2008. Two follow-ups were carried out, the
first one in 2012–2013 and the other during 2015–2016(14,15).
Settings and participants
At baseline, individuals aged≥30 years who reported living
permanently in the selected rural and urban areas were
invited to participate in the study after a single-stage ran-
dom sampling method. Rural dwellers were recruited from
the district of San Jose de Secce in Huanta, Ayacucho.
Rural-to-urban migrants and urban dwellers were selected
from Las Pampas de San Juan de Miraflores, Lima.
Participants unable to consent and pregnant women were
excluded(14).
Enrolment at baseline was made through a single-stage
random sampling technique. In San Jose de Secce, the rural
site, a census was conducted in 2007. In the case of Lima,
the urban area, a local census was updated in that year.
Those who were born and lived permanently in Las
Pampas de San Juan de Miraflores, Lima, were included
in the urban group, whereas those who reported to perma-
nently live in Las Pampas de San Juan de Miraflores at the
time of the baseline assessment but were born in Ayacucho
were considered in the migrant group. A face-to-face
administered questionnaire as well as clinical and labora-
tory assessments were conducted to obtain data related
to CVD risk profile and sociodemographic characteristics.
Only those with completed information were included in
the cohort baseline, resulting in an overall response rate
of 61·6 % (989/1606)(14). Participants were re-evaluated
during follow-up assessments by contacting them in the
settings where they were originally enrolled in the study.
Definition of variables
Outcome variables
The two outcomes of interest were T2DM and HT. T2DM
cases were defined as: a fasting glucose level ≥126 mg/dl
obtained within 8 and 12 h of fasting, self-reported T2DM
diagnosis made by a physician, or a current record that the
participant is on antidiabetic medication. In the follow-up
assessment, new cases of T2DMwere considered only when
the participant accomplished the first two diagnostic criteria
we used at baseline. The laboratory method used for plasma
glucose measurement was the enzymatic colorimetric
(GOD-PAP, Modular P-E/Roche-Cobas, Grenzach-Whylen,
Germany) for 5 ml of whole blood.
At baseline, all cases of HT were defined by: the average
of the last two of three measurements of systolic blood pres-
sure (≥140mmHg) or diastolic blood pressure (≥90mmHg)
in the clinical assessment, the participant’s self-report of HT
diagnosis done by a physician, or currently receiving antihy-
pertensivemedication.New cases ofHT identified in the first
and second follow-up were determined by using only the
first two criteria, as the antihypertensive medication data
did not provide more information.
Exposure variables
Excessbodyfat,measuredonlyatbaseline,wasdefinedas the
exposure variable according to each skinfold measurement.
Four different areas of the body (i.e. bicipital, tricipital, sub-
scapular, suprailiac)weremeasured in triplicate inmillimetres
andassessedby the same fieldworkerusingaHoltainTanner/
WhitehouseSkinfoldCaliper calibrated to thenearest 0·2 mm.
The average of the three measures for each skinfold was cal-
culated and utilized for further estimations. The Durnin–
Womersley density formula was used to estimate the body
density according to each skinfold measurement as well as
the overall fat obesity, defined as the total sum of all the four
skinfolds(16). Then, the SIRI equation was used to calculate
BF% for each skinfold parameter(17). Sex-specific cut-off
points (>25% for males and 33% for females) established
by the Spanish Society for Obesity Studies were used(18).
For comparison, obesity, defined by BMI (≥30 kg/m2), WC
(cut-off point ≥80 cm for women and ≥90 cm for men),
waist-to-hip ratio (WHR; cut-off point ≥0·85 for women and
≥0·95 for men) andwaist-to-height ratio (WHtR; cut-off point
≥0·5), were considered as other exposure variables of
interest(18,19). Anthropometric assessments were conducted
following standardized procedures by trained fieldworkers.
Other variables
The following sociodemographic variables, assessed at base-
line,were also included in the analysis as potential confound-
ers: sex (female v. male), age (<50 v. ≥50 years), education
level (non/some primary, complete primary, secondary or
more), and socio-economic status based on a wealth index
and split into tertiles. Additionally, non-healthy behavioural
risk factorswere also assessed. Physical activity was assessed
through the International Physical Activity Questionnaire
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(IPAQ). Levels in MET-min/week were categorized into low
and medium/high (where MET is metabolic equivalent of
task). Heavy drinking was defined as either the self-report
of having a hangover or having ≥6 drinks on the same occa-
sion at least once per month. Finally, tobacco consumption
was defined as current daily smoking.
Statistical analysis
The statistical software package Stata version 13 for
Windows was used for analyses. Initially, the description
of the study population by study groups (rural, rural-
to-urban migrant and urban) defined at baseline was
conducted. Means and SD, as well as proportions were
calculated and presented according to the population sub-
groups. Comparisons were performed using the one-way
ANOVA and χ2 tests as required.
For the incidence analysis, we excluded those partici-
pants who were diagnosed with HT or T2DM at baseline
accordingly. Incidence rates and associated 95 % CI were
estimated in person-years by adding the follow-up times
of re-contacted participants. However, for those with a
new diagnosis of T2DM or HT, only half of the time
between their baseline and follow-up assessment was used
in this sum, since the actual date of diagnosis was unknown
(actuarial method). Since T2DM and HT diagnosis status
were not available for those dead and lost to follow-up,
information of the last follow-up was used if possible.
To determine the associations of interest, Poisson regres-
sion models, using link log and robust SE to account for the
cluster effect, were utilized to report risk ratios and 95% CI
as the risk of death was assumed constant over time. Two
regression models adjusted by different confounders were
developed. Model 1 adjusted for sex, age, education, assets
index, population group, heavy drinking, currently daily
smoking and physical activity. Model 2 adjusted for every-
thing in model 1 plus BMI. In addition, population attribut-
able fraction (PAF) was also calculated using the ‘punaf ’
command in Stata(20,21) and compared between models.
Results
Characteristics of the study population at baseline
At the baseline enrolment, 988 participants completed the
study. Overall age was 48·0 (SD 12·0) years and 47 % were
male. Baseline prevalence of T2DM and HT was 4·1 and
16·1 %, respectively, being higher in the urban group
(Table 1). The mean of all skinfold measurements, as well
as the sum of them, was significantly higher in the both
urban andmigrant groups, compared with those who were
rural dwellers (P < 0·001, Table 1).
Skinfold measurements and incidence and risk of
type 2 diabetes mellitus
A total of 106 (10·7 %) participants were lost-to-follow up,
and fifty-seven (5·8 %) died. For the T2DM incidence, we
excluded those who had T2DM diagnosis at baseline
(n 40; see online supplementary material, Supplemental
Fig. S1). The mean follow-up was 7·6 (SD 1·3) years,
leading to 6068 person-years of follow-up. We identified
sixty-one new T2DM cases, resulting in an overall inci-
dence of 1·0 (95 % CI 0·8, 1·3) per 100 person-years.
T2DM incidences according to the different obesity
approaches are described in Table 2.
Overall fat obesity was associated with a 2·3-fold risk for
T2DM. Bicipital and subscapular excess of BF% were the
measurements strongly associated with higher risk of
T2DM, with almost 3-fold and 6-fold risk, respectively.
PAF due to subscapular fat was greater than for other
common anthropometric measurements such as BMI, WC
and WHtR (Table 2). After controlling for BMI, results
showed a strong association between subscapular skinfold
thickness and the risk of T2DMwith a small variation in PAF.
Skinfold measurements and incidence and risk of
hypertension
In the case ofHT,we excluded 160 participants diagnosed at
baseline (see online supplementary material, Supplemental
Fig. S2). The mean follow-up was 6·5 (SD 2·5) years leading
to 4850 person-years of follow-up. A total of 128 new cases
of HT were identified, which resulted in an incidence of
2·6 (95 % CI 2·2, 3·1) per 100 person-years. HT incidences
according to the different obesity approaches are described
in Table 3.
Obesity-defined subscapular and suprailiac fat, as well
as the sum of all measurements, were significantly associ-
ated with higher risk of developing HT. Although almost all
of the obesity anthropometric markers were associated
with the risk of developing HT, the sum of all skinfold mea-
surements, suprailiac fat, WHtR and subscapular fat
showed higher PAF (52·2, 47·7, 46·5 and 42·1 %, respec-
tively; Table 3). After controlling for BMI, associations
and their respective PAF were similar to those obtained
by models without that adjustment.
Discussion
We found a strong association between BF%, assessed by
skinfold thickness, and the risk of developing T2DM and
HT even after adjusting for several confounders, including
BMI. Obesity defined by BF% in the subscapular area was
the strongest anthropometric marker associated with the
risk of T2DM, whereas overall fat obesity was most greatly
associated with developing HT.
Skinfold thickness measurements as predictor of
type 2 diabetes mellitus
The impact of obesity, assessed by BMI, WC andWHtR, on
the development of T2DM has been largely described in
large cohort prospective studies(22,23). However, there is
still very limited prospective information assessing the
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association of skinfold thickness with incident T2DM. To
our knowledge, there is no specific recommendation
about the use of an anthropometric measurement as a
marker for T2DM risk prediction besides BMI and
WC(24,25). Our findings provide evidence favouring the
utility of measuring skinfolds as a laboratory-free marker
Table 1 Characteristics of the sample at baseline by population group; PERU MIGRANT Cohort Study, 2007–2008
Rural Migrant Urban
P value*N, n or mean % or SD N, n or mean % or SD N, n or mean % or SD
Sex 200 589 199
Female 106 53·0 309 52·5 107 53·8 0·95
Age 200 589 199
≥50 years 84 42·0 252 42·8 89 44·8 0·83
Asset index 200 589 199
Low 123 61·5 242 41·1 67 33·7 <0·001
Middle 14 7·0 156 26·5 69 34·7
High 63 31·5 191 32·4 63 31·7
Education 200 588 198
None/some primary 132 66·0 183 31·1 13 6·6 <0·001
Complete primary 29 14·5 99 16·8 23 11·6
Some secondary or more 39 19·5 306 52·1 162 81·8
Current daily smoking 200 587 199
Yes 1 0·5 15 2·6 17 8·5 <0·001
Heavy drinking 200 589 199
Yes 24 12·0 48 8·2 19 9·6 0·26
Physical activity level 200 582 198
Low 4 2·0 173 29·7 78 39·4 <0·001
Biceps skinfold (mm), continuous 198 583 198
Mean and SD 5·0 2·4 11·1 8·4 15·4 9·6 <0·001
Biceps skinfold categorized (obesity) 198 583 198
n and % 22 11·0 362 61·5 158 79·4 <0·001
Triceps skinfold (mm), continuous 198 583 198
Mean and SD 11·1 5·2 22·7 11·3 28·6 12·2 <0·001
Triceps skinfold categorized (obesity) 198 583 198
n and % 39 19·5 478 81·2 175 87·9 <0·001
Subscapular skinfold (mm), continuous 198 583 198
Mean and SD 12·7 5·5 20·8 7·7 23·8 8·3 <0·001
Subscapular skinfold categorized (obesity) 198 583 198
n and % 49 24·5 389 66·0 158 79·4 <0·001
Suprailiac skinfold (mm), continuous 197 581 197
Mean and SD 13·2 10·7 26·7 8·8 28·4 9·3 <0·001
Suprailiac skinfold categorized (obesity) 197 581 197
n and % 62 31·0 495 84·0 170 85·4 <0·001
Sum of all skinfolds (mm), continuous 197 581 197
Mean and SD 42·1 20·1 81·4 30·6 96·0 35·1 <0·001
Sum of all skinfolds categorized (obesity) 197 581 197
n and % 43 21·5 464 78·8 171 85·9 <0·001
BMI (kg/m2), continuous 200 589 199
Mean and SD 23·2 2·7 27·0 4·3 28·3 5·4 <0·001
BMI categorized (obesity) 200 589 199
n and % 6 3·0 124 21·1 68 34·2 <0·001
WC (cm), continuous 197 587 198
Mean and SD 76·2 8·5 88·1 9·9 91·4 12·1 <0·001
WC categorized (obesity) 197 587 198
n and % 33 16·5 356 60·4 133 66·8 <0·001
WHR, continuous 196 586 198
Mean and SD 0·8 0·1 0·9 0·1 0·92 0·7 <0·001
WHR categorized (obesity) 196 586 198
n and % 66 33·0 424 72·0 129 64·8 <0·001
WHtR, continuous 197 586 198
Mean and SD 0·5 0·1 0·6 0·1 0·6 0·1 <0·001
WHtR categorized (obesity) 197 586 198
n and % 94 47·7 511 87·2 170 85·9 <0·001
HT 200 588 199
n and % 24 12·0 76 12·9 59 29·7 <0·001
T2DM 199 589 199
n and % 3 1·5 21 3·6 16 8·0 0·003
N, number of observations; n, frequency; WC, waist circumference; WHR, waist-to-hip ratio; WHtR, waist-to-height ratio; HT, hypertension; T2DM, type 2 diabetes mellitus.
Values are presented as N, n and % for categorical variables or N, mean and SD for continuous variables.
*The χ2 test, t test and ANOVA were used to assess differences between groups according to the type of variable.
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for the risk of T2DM in non-specialist and low-resource
settings.
Upper-body fat, known as truncal fat, has been associ-
ated with an increased insulin resistance among men(26).
Many markers of insulin secretion and its metabolism have
been studied according to fat distribution. These studies
have indicated that visceral and upper-body fat are more
related to the release of NEFA and their accumulation in
the liver, which subsequently leads to glucose metabolism
impairment and even cardiovascular mortality(27–29). Few
observational studies have approached the relationship
between subscapular skinfold thickness and the risk of
developing T2DM. Of these studies, only three were pro-
spective in nature(12,13,30). Mensik et al. reported that a
Table 2 Incidence and risk of type 2 diabetes mellitus according to obesity defined by skinfolds; PERUMIGRANT Cohort Study, 2007–2016
Incidence per 100
person-years Crude model Model 1*
PAF (%)
Model 2†
PAF (%)Incidence 95 % CI RR 95 % CI RR 95 % CI RR 95 % CI
Biceps fat
Yes 1·47 1·11, 1·94 3·23 1·72, 6·07 2·75 1·39, 5·41 51·1 1·91 0·90, 4·08 38·3
Triceps fat
Yes 1·22 0·93, 1·60 2·47 1·17, 5·19 1·84 0·82, 4·15 39·8 1·36 0·58, 3·18 22·8
Subscapular fat
Yes 1·52 1·17, 1·98 6·87 2·75, 17·17 6·40 2·52, 16·23 77·5 5·04 1·85, 13·73 73·6
Suprailiac fat
Yes 1·20 0·92, 1·56 2·71 1·17, 6·30 2·11 0·90, 4·96 47·4 1·65 0·66, 4·12 35·5
Overall fat obesity
Yes 1·26 0·96, 1·64 2·98 1·35, 6·54 2·34 1·10, 4·99 50·7 1·74 0·77, 3·94 37·6
Obesity (WC)
Yes 1·44 1·08, 1·92 2·77 1·52, 5·04 2·31 1·15, 4·66 43·5 1·45 0·64, 3·28 23·7
Obesity (WHR)
Yes 1·26 0·95, 1·67 2·37 1·32, 4·27 2·08 1·02, 4·26 41·7 1·59 0·76, 3·34 29·8
Obesity (WHtR)
Yes 1·15 0·88, 1·49 2·79 1·21, 6·46 2·40 0·94, 6·11 53·5 1·70 0·63, 4·61 37·8
Obesity (BMI)
Yes 2·52 1·75, 3·62 3·89 2·36, 6·42 3·53 2·02, 6·16 34·1 – –
RR, risk ratio; PAF, population attributable fraction; WC, waist circumference; WHR, waist-to-hip ratio; WHtR, waist-to-height ratio.
Bold indicates significant results (P< 0·05) according to 95 % CI.
*Model 1 adjusted by age, sex, education, assets index, current daily smoking, heavy drinking, population group and physical activity level.
†Model 2 adjusted by age, sex, education, assets index, current daily smoking, heavy drinking, population group, physical activity level and BMI (in categories).
Table 3 Incidence and risk of hypertension according to obesity defined by skinfolds; PERU MIGRANT Cohort Study, 2007–2016
Incidence per 100
person-years Crude model Model 1*
PAF (%)
Model 2†
PAF (%)Incidence 95 % CI RR 95 % CI RR 95 % CI RR 95 % CI
Biceps fat
Yes 3·19 2·57, 3·97 1·52 1·05, 2·21 1·92 1·20, 3·08 30·3 1·68 1·02, 2·77 25·7
Triceps fat
Yes 2·68 2·18, 3·29 1·02 0·69, 1·51 1·24 0·74, 2·09 13·7 1·08 0·63, 1·86 5·3
Subscapular fat
Yes 3·36 2·75, 4·11 1·96 1·31, 2·94 2·35 1·46, 3·78 42·1 2·15 1·30, 3·55 39·2
Suprailiac fat
Yes 2·96 2·45, 3·58 1·64 1·02, 2·64 2·33 1·31, 4·13 47·7 2·19 1·22, 3·94 45·4
Overall fat obesity
Yes 3·12 2.57, 3·78 1·82 1·17, 2·85 2·85 1·64, 4·96 52·2 2·64 1·49, 4·67 50·0
Obesity (WC)
Yes 3·36 2·71, 4·17 1·71 1·18, 2·48 2·12 1·37, 3·29 33·8 1·86 1·16, 3·00 29·7
Obesity (WHR)
Yes 3·20 2·62, 3·91 1·87 1·25, 2·81 2·12 1·32, 3·41 39·2 1·93 1·17, 3·20 35·8
Obesity (WHtR)
Yes 2·89 2·40, 3·49 1·64 1·00, 2·71 2·21 1·28, 3·80 46·5 2·01 1·14, 3·52 42·7
Obesity (BMI)
Yes 4·13 2·97, 5·76 1·78 1·18, 2·67 1·91 1·21, 3·01 13·0 – –
RR, risk ratio; PAF, population attributable fraction; WC, waist circumference; WHR, waist-to-hip ratio; WHtR, waist-to-height ratio.
Bold indicates significant results (P< 0·05) according to 95 % CI.
*Model 1 adjusted by age, sex, education, assets index, current daily smoking, heavy drinking, population group and physical activity level.
†Model 2 adjusted by age, sex, education, assets index, current daily smoking, heavy drinking, population group, physical activity level and BMI (in categories).
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greater subscapular skinfold thickness was more strongly
associated with the risk of transient and persistent impaired
glucose tolerance after 4 months of follow-up compared
with BMI,WC and the sum of all skinfoldmeasurements(12).
However, Chei et al. questioned this association, as only a
marginal significant risk for T2DM and HT was found(13).
Data regarding physical activity and sociodemographic
characteristics were not available in this latter report, leav-
ing room to better assess the association by including fur-
ther confounders as we did herein. Sosenko et al. noted a
strong association between subscapular skinfold thickness
and non-insulin-dependent diabetes. Compared with BMI
and WHtR, subscapular skinfold thickness was superiorly
associated with T2DM, even after controlling for sex(30).
Some studies suggest that the relationship between insu-
lin secretion and high-carbohydrate diets, which are par-
ticularly common in Peru and other Latin American
countries(31), varies according to phenotype and body fat
distribution. The positive association between abdominal
obesity and T2DM is clear and seems to be stronger when
other criteria of the metabolic syndrome (e.g. high choles-
terol) are present(32–34). Moreover, in patients with a history
of vascular disease, WC has a positive association with
T2DM risk(35). A diet rich in carbohydrates would increase
the abdominal perimeter, leading to high levels of inflam-
mation markers related to T2DM, such as IL-6, complement
factor C3 and C-reactive protein(36). In Asian populations,
WC has been associated not only with T2DM but also with
diabetic retinopathy(37). Among Hispanics, data are limited.
Mexican populations had greater levels of insulin secretion
after oral glucose intake unlike to white counterparts(38).
Finally, truncal fat is linked to parental history of T2DM,
which is also an established risk factor for T2DM(39).
Overall, the assessment of body fat distribution could play
an important role in T2DM screening and follow-up.
Skinfold thickness measurements as predictor of
hypertension
Data regarding the association between skinfold thickness
and HT are even more limited. To our knowledge, there is
only one study addressing this association prospectively.
The Kaunas Cardiovascular Cohort Risk Study conducted
in Lithuania showed that an increased skinfold thickness
measured in childhood was not associated with HT in
adulthood, after 35 years of follow-up(40). There are chemi-
cal changes during adolescence that may explain why skin-
fold thickness assessed during childhood might not reflect
final fat distribution in adulthood(41). In addition, studies in
twins have reported that BMI and skinfolds vary with age
and sex independently of heritability, and that skinfold
thickness measurements performed in childhood actually
overestimate BF%(42). Our study focused only on adults
and demonstrated the long-term effect of body fat distribu-
tion on blood pressure outcomes.
A few cross-sectional studies, mainly in children, have
considered skinfold thickness measurements as exposure
variables while assessing HT or blood pressure as out-
comes. Khadilkar et al. found a relevant association
between higher blood pressure and tricipital skinfold thick-
ness in children aged 5–17 years(43). Ying-Xiu et al.
assessed upper-body fat as the sum of tricipital and sub-
scapular skinfold thicknesses, obtaining similar results in
12-year-old children(44). Okosun et al. found that truncal
obesity, abdominal obesity and their co-occurrence had
higher odds of HT, especially in adult women(45). Our
longitudinal study confirms these associations. A cross-
sectional analysis in young Mexican women (mean age
= 29·6 (SD 5·4) years) reported that the sum of all skinfold
thicknesses was almost equally efficient in predicting HT
compared with BMI and WC(46); however, in our prospec-
tive analysis, BMI had the weakest association and lowest
PAF. In that sense, our results are physiologically compat-
ible with previous studies where subscapular, suprailiac
and tricipital skinfold thickness had associations with stan-
dard indicators of organ damage due to HT(47).
Our findings suggest that body fat located in the subscap-
ular area is a risk factor for developing T2DM and HT. Thus,
subscapular skinfold thickness measurement could be used
as an individual potential tool or part of a risk score to iden-
tify individuals at high risk for developing T2DM and HT. In
addition to BMI, WHtR and overall fat obesity could be also
used as a screening tool for HT. In resource-limited settings,
where laboratory analysis is not always included in the min-
imal health insurance package, these anthropometric
parameters could provide a cost-effective and individual-
ized approach identify andmonitor patients at risk for devel-
oping either of these two conditions.
Regardless of the setting, inserting some skinfold param-
eters may improve the surveillance and screening of CVD
risk factors by identifying individuals at high risk for devel-
oping T2DM and HT. The strong association and high PAF
percentages from subscapular skinfold thickness support
the utility of using this anthropometric marker as part of
the general clinical evaluation in adults.
Strengths and limitations
The PERU MIGRANT Cohort Study has three well-defined
sociodemographic groups, controlling our models by
urbanization exposure as in previous studies(48,49). In addi-
tion, our regression analysis allows us to pursue PAF of all
the anthropometric measurements and compare them.
Nevertheless, our study remained with limitations that
should be declared. First, potential misclassification of
T2DM cases can arise because oral glucose tolerance
was not used as diagnostic method(14). However, our main
findings will not change since the under-diagnosis of T2DM
would have a negative impact in the strength of the asso-
ciations, which implies that risk of developing T2DMwould
be even greater. Second, selection bias might arise due to
difference in baseline response rates among population
groups, which was higher among rural dwellers(14).
Third, skinfold thickness measurement has its own
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limitations such as variance among measurers and calliper
types, ethnic phenotypes, etc. In order to minimize the
effect of these variations, we standardized the skinfold
thickness measurements at baseline. Nevertheless, we rec-
ognize potential additional bias due to variation of body fat
during the observation period, which was not assessed
periodically by skinfold thickness. Finally, data regarding
diet were not collected, representing a potential but
minimal bias because of its relationship with body fat dis-
tribution according to the intake of simple and complex
carbohydrates and saturated fat, which typically accumu-
lates in WC. Therefore, further studies are needed to
address the impact of diet patterns.
Conclusions
There is evidence of a strong association between subscap-
ular and overall fat obesity assessed through skinfold thick-
ness and the risk of developing T2DM and HT. Moreover,
after adjusting for obesity according to BMI, which is used
the most in daily clinical practice, subscapular obesity
remained as one of the best predictors for T2DM. We
remark that BMI and WC, commonly used anthropometric
measurements, had lower PAF, particularly for HT. Our
findings suggest that skinfold thickness, if used as part of
routine assessments, might improve the detection process
of T2DM and HT in settings without clinical specialists or
accessible laboratory support. Nevertheless, considering
the limitations of the skinfold thickness measurements,
implementation-type studies are needed in order to disen-
tangle the impact of subscapular skinfold thickness mea-
surement as part of the routine clinical examination in
elderly or overweight patients.
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